Company Overview:
Dyax is focused on advancing novel biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications. Dyax utilizes its proprietary drug discovery technology to identify antibody, small protein and peptide compounds for clinical development. DX-88 (ecallantide) and other compounds in Dyax's pipeline were identified using its technology.
This Exhibitor offers products & services in the following categories:
• Biotechnology and Related Specialties
» Biotechnology Company
» Therapeutics